Prebiotic supplementation in full-term neonates: a systematic review of randomized controlled trials

Shripada Rao1, Ravisha Srinivasjois, Sanjay Patole

  • 1Department of Neonatal Pediatrics, Princess Margaret Hospital for Children, Roberts Road, Subiaco, Perth, Western Australia 6008, Australia. Shripada.Rao@health.wa.gov.au

Insights

Prebiotic supplementation in infant formula is well tolerated and promotes beneficial gut bacteria in full-term neonates. This leads to softer stools similar to breastfed infants, though larger studies are needed for long-term effects.

Area of Science:

  • Neonatal nutrition and gut microbiome research.
  • Clinical trials and systematic reviews in pediatrics.
  • Gastrointestinal health and infant development.

Background:

  • Prebiotics are non-digestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon.
  • Understanding the impact of prebiotics on the gut microbiome and health outcomes in neonates is crucial for optimizing infant nutrition.

Purpose of the Study:

  • To systematically review randomized controlled trials (RCTs) evaluating the efficacy and safety of prebiotic supplementation in full-term neonates.
  • To assess the impact of prebiotics on gut microbiota composition, stool characteristics, and infant growth.

Main Methods:

  • A systematic review of RCTs was conducted using multiple databases (Cochrane, MEDLINE, EMBASE, CINAHL) and conference proceedings.
  • Eleven eligible trials (n=1459) compared formula milk with or without prebiotic supplementation, initiated within 28 days of birth for at least 2 weeks.
  • Outcomes included stool colony counts, pH, consistency, frequency, anthropometry, and intolerance symptoms.

Main Results:

  • Prebiotic supplementation significantly increased bifidobacteria counts and reduced stool pH.
  • Infants receiving prebiotics had softer, more frequent stools, resembling those of breastfed infants.
  • While weight gain was slightly improved, supplementation was generally well-tolerated, with one study noting increased diarrhea, irritability, and eczema.

Conclusions:

  • Prebiotic-supplemented formula is safe and well-tolerated in full-term infants.
  • It effectively modulates the gut microbiota, increasing beneficial bacteria and altering stool characteristics.
  • Further large-scale trials with long-term follow-up are necessary to confirm sustained benefits.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...